BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 15641488)

  • 1. Esophageal carcinoma: current controversial topics.
    Patel M; Ferry K; Franceschi D; Kaklamanos I; Livingstone A; Ardalan B
    Cancer Invest; 2004; 22(6):897-912. PubMed ID: 15641488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of advanced-stage operable esophageal cancer.
    Bharat A; Crabtree T
    Surg Clin North Am; 2012 Oct; 92(5):1179-97. PubMed ID: 23026277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Staging and neoadjuvant therapy of squamous cell carcinoma of esophagus].
    Benhidjeb T; Moesta KT; Schlag PM
    Ther Umsch; 2001 Mar; 58(3):165-73. PubMed ID: 11305155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant versus adjuvant chemoradiation for stage II-III esophageal squamous cell carcinoma: a single institution experience.
    Chen Y; Hao D; Wu X; Xing W; Yang Y; He C; Wang W; Liu J; Wang J
    Dis Esophagus; 2017 Jul; 30(7):1-7. PubMed ID: 28475725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A retrospective comparison of neoadjuvant chemoradiotherapy regimens for locally advanced esophageal cancer.
    Sanford NN; Catalano PJ; Enzinger PC; King BL; Bueno R; Martin NE; Hong TS; Wo JY; Mamon HJ
    Dis Esophagus; 2017 Jul; 30(7):1-8. PubMed ID: 28475728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of clinical T2N0M0 esophageal cancer.
    Hardacker TJ; Ceppa D; Okereke I; Rieger KM; Jalal SI; LeBlanc JK; DeWitt JM; Kesler KA; Birdas TJ
    Ann Surg Oncol; 2014 Nov; 21(12):3739-43. PubMed ID: 25047477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Refining esophageal cancer staging after neoadjuvant therapy: importance of treatment response.
    Barbour AP; Jones M; Gonen M; Gotley DC; Thomas J; Thomson DB; Burmeister B; Smithers BM
    Ann Surg Oncol; 2008 Oct; 15(10):2894-902. PubMed ID: 18663531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Esophageal Cancer: New Insights into a Heterogenous Disease.
    Krug S; Michl P
    Digestion; 2017; 95(4):253-261. PubMed ID: 28384630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current diagnosis and therapy of esophageal carcinoma].
    Mühr-Wilkenshoff F; Stahl M; Faiss S; Zeitz M; Scherübl H
    Z Gastroenterol; 2004 Jul; 42(7):615-21. PubMed ID: 15248111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. International survey on esophageal cancer: part II staging and neoadjuvant therapy.
    Boone J; Livestro DP; Elias SG; Borel Rinkes IH; van Hillegersberg R
    Dis Esophagus; 2009; 22(3):203-10. PubMed ID: 19191855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endoscopic ultrasound for esophageal and gastroesophageal junction cancer: Impact of increased use of primary neoadjuvant therapy on preoperative locoregional staging accuracy.
    DeWitt J; Kesler K; Brooks JA; LeBlanc J; McHenry L; McGreevy K; Sherman S
    Dis Esophagus; 2005; 18(1):21-7. PubMed ID: 15773837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between tumor-associated proteins and response to neoadjuvant treatment in patients with advanced squamous-cell esophageal cancer.
    Farkas R; Pozsgai E; Bellyei S; Cseke L; Szigeti A; Vereczkei A; Marton S; Mangel L; Horvath OP; Papp A
    Anticancer Res; 2011 May; 31(5):1769-75. PubMed ID: 21617238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant chemoradiotherapy for esophageal carcinoma.
    Zhang X; Watson DI; Jamieson GG; Bessell JR; Devitt PG
    Dis Esophagus; 2005; 18(2):104-8. PubMed ID: 16053485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined modality therapy of esophageal cancer.
    Juergens RA; Forastiere A
    J Natl Compr Canc Netw; 2008 Oct; 6(9):851-60; quiz 861. PubMed ID: 18926094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early diagnosis and management of esophageal and gastric cancer.
    Lang GD; Konda VJ
    Minerva Gastroenterol Dietol; 2013 Dec; 59(4):357-76. PubMed ID: 24212354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study between endoscopic ultrasonography and positron emission tomography-computed tomography in staging patients with esophageal squamous cell carcinoma.
    Yen TJ; Chung CS; Wu YW; Yen RF; Cheng MF; Lee JM; Hsu CH; Chang YL; Wang HP
    Dis Esophagus; 2012 Jan; 25(1):40-7. PubMed ID: 21595776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of restaging endoscopic ultrasound after neoadjuvant therapy for esophageal cancer.
    Griffin JM; Reed CE; Denlinger CE
    Ann Thorac Surg; 2012 Jun; 93(6):1855-9; discussion 1860. PubMed ID: 22516835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current choices and prospects in management of postoperative esophageal cancer patients.
    Tu CC; Hsu PK
    Asian J Surg; 2019 Jan; 42(1):81-84. PubMed ID: 30121147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CMISG1701: a multicenter prospective randomized phase III clinical trial comparing neoadjuvant chemoradiotherapy to neoadjuvant chemotherapy followed by minimally invasive esophagectomy in patients with locally advanced resectable esophageal squamous cell carcinoma (cT
    Tang H; Tan L; Shen Y; Wang H; Lin M; Feng M; Xu S; Guo W; Qian C; Liu T; Zeng Z; Hou Y; Yu Z; Jiang H; Li Z; Chen C; Lian C; Du M; Li H; Xie D; Yin J; Zhao N; Wang Q
    BMC Cancer; 2017 Jun; 17(1):450. PubMed ID: 28659128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synchronous triple primary cancers of the pharynx and esophagus.
    Kataoka S; Omae M; Horiuchi Y; Ishiyama A; Yoshio T; Hirasawa T; Yamamoto Y; Tsuchida T; Fujisaki J; Yamada K; Igarashi M
    Clin J Gastroenterol; 2017 Jun; 10(3):208-213. PubMed ID: 28315155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.